Regeneron announced that it has entered into a global collaboration agreement with Tessera Therapeutics to commercialize and ...

Eli Lilly has announced a price reduction for Zepbound single-dose vials, targeting improved affordability for self-pay ...

New data shows that China and the US dominate breast cancer clinical trial expertise while lower-income countries remain ...

Along with the deployment and integration the new agentic AI tool, FDA is also launching an agentic AI challenge for its ...

Patient-centric evidence, such as PROs and RWE, offers insights into patients' needs, enhancing drug development beyond traditional endpoints. Challenges include increased complexity and regulatory ...